A detailed history of Commonwealth Equity Services, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 11,098 shares of MCRB stock, worth $8,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,098
Previous 11,368 2.38%
Holding current value
$8,545
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$0.7 - $1.48 $189 - $399
-270 Reduced 2.38%
11,098 $11,000
Q1 2024

Apr 29, 2024

BUY
$0.75 - $1.56 $8,526 - $17,734
11,368 New
11,368 $9,000
Q3 2023

Oct 23, 2023

BUY
$2.33 - $5.07 $25,723 - $55,972
11,040 New
11,040 $26,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $95.5M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.